The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Cell & Gene
    • Bioprocessing
    • Drug Delivery
    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Regulation & Standards
    • Small Molecules
    • Supply Chain
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • eBooks
    • Content Hubs
Subscribe
Subscribe
The Medicine Maker / Issues / 2026 / June / How Zealand Pharma Is Scaling Quality Without Complexity
Bioprocessing Interviews Technology & Manufacturing Digital Technologies Quality & Compliance Regulation & Standards Standards & Regulation Sponsored

How Zealand Pharma Is Scaling Quality Without Complexity

How connected quality systems can help growing biotechs remain agile.

06/29/2026 0 min read Video

Share

As biotech companies grow, so does the complexity of their quality processes. How can teams expand without creating disconnected systems, duplicated work, and barriers for users?

Kamilla Vagtborg, Director and Head of Quality Systems at Zealand Pharma, explains how bringing documents, training, quality processes, and validation into one ecosystem can improve transparency and make information easier to navigate. She also discusses the value of investing in the right infrastructure early while keeping systems simple and adaptable as the organization evolves.

Watch the interview.

Newsletters

Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Recommended

Related Content

Musings from The Power List: Christine Allen
Development & Clinical Small Molecules Interviews
Musings from The Power List: Christine Allen

August 28, 2026

2 min read

Christine Allen believes AI will connect every stage of drug development, but only if it remains guided by human expertise

Green Shoots, Gray Skies
Biopharma Interviews Business & Trends
Green Shoots, Gray Skies

August 26, 2026

9 min read

Jon Rees sees signs of recovery following biotech's post-pandemic funding reset, but there’s no going back to the “old normal”

What Pharma Can Learn From Military Intelligence
Interviews Business & Trends
What Pharma Can Learn From Military Intelligence

August 21, 2026

5 min read

Former military intelligence officer Tony Page discusses what pharma can learn from early warning systems, decision cycles, and the discipline of intelligence

Musings from The Power List: Daniel Vitt
Small Molecules Drug Discovery Development & Clinical
Musings from The Power List: Daniel Vitt

August 20, 2026

6 min read

From multiple sclerosis to AI-driven discovery, Daniel Vitt reflects on the future of drug development

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions: